The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury.
The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury.
复制标题
DOI:
10.1016/j.redox.2023.103022
复制
发表时间:
2024-04
期刊:
影响因子:
11.4
通讯作者:
Allen, Bryan G.
中科院分区:
文献类型:
--
作者:
Mapuskar, Kranti A.;Pulliam, Casey F.;Tomanek-Chalkley, Ann;Rastogi, Prerna;Wen, Hsiang;Dayal, Sanjana;Griffin, Benjamin R.;Zepeda-Orozco, Diana;Sindler, Amy L.;Anderson, Carryn M.;Beardsley, Robert;Kennedy, Eugene P.;Spitz, Douglas R.;Allen, Bryan G.
关键词:
Cisplatin contributes to acute kidney injury (AKI) and chronic kidney disease (CKD) that occurs with greater frequency and severity in older patients. Age-associated cisplatin sensitivity in human fibroblasts involves increased mitochondrial superoxide produced by older donor cells. Young and old C57BL/6 J murine models of cisplatin-induced AKI and CKD were treated with the SOD mimetic avasopasem manganese to investigate the potential antioxidant and anti-inflammatory effects. Adverse event reporting from a phase 2 and a phase 3 randomized clinical trial (NCT02508389 and NCT03689712) conducted in patients treated with cisplatin and AVA was determined to have established the incidence and severity of AKI. Cisplatin-induced AKI and CKD occurred in all mice, however, was more pronounced in older mice. AVA reduced cisplatin-induced mortality, AKI, and CKD, in older animals. AVA also alleviated cisplatin-induced alterations in mitochondrial electron transport chain (ETC) complex activities and NADPH Oxidase 4 (NOX4) and inhibited the increased levels of the inflammation markers, TNFα, IL1, ICAM-1, and VCAM-1. Analysis of age-stratified subjects treated with cisplatin from clinical trials (NCT02508389, NCT03689712) also supported that the incidence of AKI increased with age and AVA reduced age-associated therapy-induced adverse events (AE), including hypomagnesemia, increased creatinine, and AKI. Older mice and humans are more susceptible to cisplatin-induced kidney injury, and treatment with AVA mitigates age-associated damage. Mitochondrial ETC and NOX4 activities represent sources of superoxide production contributing to cisplatin-induced kidney injury, and pro-inflammatory cytokine production and endothelial dysfunction may also be increased by superoxide formation.
登录
查看更多内容
DOI:
10.5049/ebp.2014.12.2.55
发表时间:
2014-12
期刊:
Electrolyte & blood pressure : E & BP
影响因子:
--
作者:
Oh GS;Kim HJ;Shen A;Lee SB;Khadka D;Pandit A;So HS
通讯作者:
So HS
DOI:
10.1016/j.ijrobp.2017.10.019
发表时间:
2018-02-01
期刊:
International journal of radiation oncology, biology, physics
影响因子:
--
作者:
Anderson CM;Sonis ST;Lee CM;Adkins D;Allen BG;Sun W;Agarwala SS;Venigalla ML;Chen Y;Zhen W;Mould DR;Holmlund JT;Brill JM;Buatti JM
通讯作者:
Buatti JM
DOI:
10.1006/bmmb.1994.1004
发表时间:
1994-02-01
期刊:
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY
影响因子:
--
作者:
BIRCHMACHIN, MA;BRIGGS, HL;TURNBULL, DM
通讯作者:
TURNBULL, DM
影响因子:
2.8
作者:
Liu JQ;Cai GY;Wang SY;Song YH;Xia YY;Liang S;Wang WL;Nie SS;Feng Z;Chen XM
通讯作者:
Chen XM
DOI:
10.1007/978-1-4939-9424-3_2
发表时间:
2019-01-01
期刊:
NADPH OXIDASES: METHODS AND PROTOCOLS
影响因子:
--
作者:
Buvelot, Helene;Jaquet, Vincent;Krause, Karl-Heinz
通讯作者:
Krause, Karl-Heinz